HUMAN PLATELET ACTIVATION AND PHOSPHOLIPID METABOLISM

人体血小板活化和磷脂代谢

基本信息

  • 批准号:
    6183639
  • 负责人:
  • 金额:
    $ 48.14万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1986
  • 资助国家:
    美国
  • 起止时间:
    1986-09-01 至 2002-12-31
  • 项目状态:
    已结题

项目摘要

Experiments described in this application focus on the characterization, regulation and physiological function of a relatively recently described group of kinases that act on phosphatidylinositosol. The enzymes are known as phosphoinositide 3-k (PI 3-K). Reactions involving these enzymes are monitored by radiolabeled product formation and Western blotting. Dr. Rittenhouse has carried out extensive preliminary studies with a specific inhibitor of PI 3-K activity is important for the signal cascade that culminates in the most important functional response of activated platelets-cohesion and aggregation. Inhibition of PI 3-K blocks agonist- stimulated exposure of activated glycoprotein Iib/IIIa, the integrin to which fibrinogen binds to platelets. This phenomenon has been detected by the GPIIb/IIIa antibody, known as PAC-1. Dr. Rittenhouse will study an extensive list of factors which regulate the activation and specificity of PI 3-Ks and the linkage of PI 3-Ks to the cytoskeleton. Among the factors to be studied are: Protein kinases, GTP-binding proteins, cytoskeletal components, and an important platelet protein-pleckstrin. Other preliminary experiments carried out by Dr. Rittenhouse have shown the product of PI 3-K activity, PI(3,4,5) P3, promotes protein phosphorylation when added to permeabilized platelets. The kinase(s) involved in this phosphorylation have not as yet been identified. The experiments on permeabilized platelets appear to be relevant to intact platelets, since wortmannin inhibits phosphorylation of specific proteins in activated platelets, and the addition of PI(3,4,5) P3 to permeabilized platelets overcomes the inhibitory effects of wortmannin on protein phosphorylation. Other experiment are designed to examine and characterize two new, additional PI 3-Ks:PI 3-K (theta) and PI 3-K(sigma). These experiments represent new research directions for Dr. Rittenhouse.
本应用程序中描述的实验侧重于表征,

项目成果

期刊论文数量(25)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Phosphatidylinositol 3,4,5-trisphosphate is formed from phosphatidylinositol 4,5-bisphosphate in thrombin-stimulated platelets.
磷脂酰肌醇 3,4,5-三磷酸由凝血酶刺激的血小板中的磷脂酰肌醇 4,5-二磷酸形成。
  • DOI:
    10.1042/bj3010415
  • 发表时间:
    1994
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Carter,AN;Huang,R;Sorisky,A;Downes,CP;Rittenhouse,SE
  • 通讯作者:
    Rittenhouse,SE
Inhibition of protein kinase C by staurosporine promotes elevated accumulations of inositol trisphosphates and tetrakisphosphate in human platelets exposed to thrombin.
星形孢菌素对蛋白激酶 C 的抑制促进暴露于凝血酶的人血小板中三磷酸肌醇和四磷酸肌醇的积累升高。
Regulation of platelet phospholipase C.
血小板磷脂酶的调节 C.
"Thrombin" receptor-directed ligand accounts for activation by thrombin of platelet phospholipase C and accumulation of 3-phosphorylated phosphoinositides.
“凝血酶”受体导向的配体负责凝血酶对血小板磷脂酶C的激活和3-磷酸化磷酸肌醇的积累。
  • DOI:
  • 发表时间:
    1991
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Huang,RS;Sorisky,A;Church,WR;Simons,ER;Rittenhouse,SE
  • 通讯作者:
    Rittenhouse,SE
Lysophosphatidic acid activates phosphoinositide 3-kinase and phospholipase C in human platelets: inhibitory effects of Wortmannin on phosphoinositide 3-kinase and aggregation.
溶血磷脂酸激活人血小板中的磷酸肌醇 3-激酶和磷脂酶 C:渥曼青霉素对磷酸肌醇 3-激酶和聚集的抑制作用。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUSAN E RITTENHOUSE其他文献

SUSAN E RITTENHOUSE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUSAN E RITTENHOUSE', 18)}}的其他基金

PLATELET ACTIVATION AND PHOSPHOLIPID METABOLISM
血小板活化和磷脂代谢
  • 批准号:
    2218949
  • 财政年份:
    1986
  • 资助金额:
    $ 48.14万
  • 项目类别:
THE PE EFFECT AND PLATELET ALPHA-ANDRENERGIC STIMULATION
PE 效应和血小板 α-雄激素刺激
  • 批准号:
    3354911
  • 财政年份:
    1986
  • 资助金额:
    $ 48.14万
  • 项目类别:
PHOSHOINOSITTIDE METABOLISM AND PLATELET SECRETION
磷酸肌醇代谢和血小板分泌
  • 批准号:
    3354907
  • 财政年份:
    1986
  • 资助金额:
    $ 48.14万
  • 项目类别:
PHOSHOINOSITTIDE METABOLISM AND PLATELET SECRETION
磷酸肌醇代谢和血小板分泌
  • 批准号:
    3354906
  • 财政年份:
    1986
  • 资助金额:
    $ 48.14万
  • 项目类别:
HUMAN PLATELET ACTIVATION AND PHOSPHOLIPID METABOLISM
人体血小板活化和磷脂代谢
  • 批准号:
    6030566
  • 财政年份:
    1986
  • 资助金额:
    $ 48.14万
  • 项目类别:
PHOSHOINOSITTIDE METABOLISM AND PLATELET SECRETION
磷酸肌醇代谢和血小板分泌
  • 批准号:
    3354904
  • 财政年份:
    1986
  • 资助金额:
    $ 48.14万
  • 项目类别:
PHOSHOINOSITTIDE METABOLISM AND PLATELET SECRETION
磷酸肌醇代谢和血小板分泌
  • 批准号:
    3354909
  • 财政年份:
    1986
  • 资助金额:
    $ 48.14万
  • 项目类别:
HUMAN PLATELET ACTIVATION AND PHOSPHOLIPID METABOLISM
人体血小板活化和磷脂代谢
  • 批准号:
    2218951
  • 财政年份:
    1986
  • 资助金额:
    $ 48.14万
  • 项目类别:
HUMAN PLATELET ACTIVATION AND PHOSPHOLIPID METABOLISM
人体血小板活化和磷脂代谢
  • 批准号:
    2735125
  • 财政年份:
    1986
  • 资助金额:
    $ 48.14万
  • 项目类别:
HUMAN PLATELET ACTIVATION AND PHOSPHOLIPID METABOLISM
人体血小板活化和磷脂代谢
  • 批准号:
    2445153
  • 财政年份:
    1986
  • 资助金额:
    $ 48.14万
  • 项目类别:

相似海外基金

Development of a highly integrated circuit using DNA and a demonstration test of the parallel computation using a complementary DNA as an operator
使用DNA的高度集成电路的开发以及使用互补DNA作为算子的并行计算的演示测试
  • 批准号:
    17K06395
  • 财政年份:
    2017
  • 资助金额:
    $ 48.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Pseudo-Complementary DNA
伪互补DNA
  • 批准号:
    8072639
  • 财政年份:
    2010
  • 资助金额:
    $ 48.14万
  • 项目类别:
Pseudo-Complementary DNA
伪互补DNA
  • 批准号:
    7871949
  • 财政年份:
    2010
  • 资助金额:
    $ 48.14万
  • 项目类别:
Quantitative analysis in neurotrophic factor genes of spinal cord with complementary DNA microarray
互补DNA微阵列定量分析脊髓神经营养因子基因
  • 批准号:
    18390411
  • 财政年份:
    2006
  • 资助金额:
    $ 48.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of gene expression following maxillofacial inflammation in rat using complementary DNA microarray
使用互补 DNA 微阵列分析大鼠颌面部炎症后的基因表达
  • 批准号:
    15390628
  • 财政年份:
    2003
  • 资助金额:
    $ 48.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Complementary DNA cloning and characterization of rat spergen-3,a spermatogenic cell-specific gene-3,expressed in mammalian spermatogenic cells
大鼠 spergen-3(生精细胞特异性基因 3,在哺乳动物生精细胞中表达)的互补 DNA 克隆和表征
  • 批准号:
    15570179
  • 财政年份:
    2003
  • 资助金额:
    $ 48.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Microbial Genome Sequencing: Gene Discovery and Mapping Tools for Ichthyophthirius: A Complementary DNA Resource
微生物基因组测序:鱼霉属基因发现和作图工具:补充 DNA 资源
  • 批准号:
    0333246
  • 财政年份:
    2003
  • 资助金额:
    $ 48.14万
  • 项目类别:
    Continuing Grant
GENE EXPRESSION ANALYSIS OF THE SPINAL CORD UNDER CHRONIC MECHANICAL COMPRESSION USING IN-HOUSE COMPLEMENTARY DNA MICROARRAY
使用内部互补 DNA 微阵列对慢性机械压迫下的脊髓进行基因表达分析
  • 批准号:
    15591563
  • 财政年份:
    2003
  • 资助金额:
    $ 48.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Effects of antisense vascular endothelial growth factor complementary DNA on the growth of human glioma cells.
反义血管内皮生长因子互补DNA对人胶质瘤细胞生长的影响。
  • 批准号:
    07671538
  • 财政年份:
    1995
  • 资助金额:
    $ 48.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
DENATURATION OF SELF-COMPLEMENTARY DNA LOOPS
自互补 DNA 环的变性
  • 批准号:
    3466758
  • 财政年份:
    1988
  • 资助金额:
    $ 48.14万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了